ResMed Inc (RSMDF) cash flow statement

RSMDFOTCSurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RMD

Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Aug 13, 2026Score 21/3011% below fair value

$22.61+0.00 (0.00%)

Close on Oct 19, 2026Market cap $33.17BP/E 22.0Yield 1.04%

ResMed Inc cash flow statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2026 2026-06-30	FY 2025 2025-06-30	FY 2024 2024-06-30	FY 2023 2023-06-30	FY 2022 2022-06-30	FY 2021 2021-06-30	FY 2020 2020-06-30	FY 2019 2019-06-30	FY 2018 2018-06-30	FY 2017 2017-06-30	FY 2016 2016-06-30	FY 2015 2015-06-30	FY 2014 2014-06-30	FY 2013 2013-06-30	FY 2012 2012-06-30	FY 2011 2011-06-30	FY 2010 2010-06-30	FY 2009 2009-06-30
Depreciation & Amortization	201	198	177	165	160	157	155	151	120	112	87	73	73	78	86	71	62	54
Stock-Based Compensation	104	92	80	71	65	64	58	52	48	46	46	48	43	38	31	31	30	26
Deferred Income Taxes	3.88	-61	-50	-45	-12	-17	-30	-50	6.95	-4.46	-1.00	3.01	9.87	-19	-13	3.36	3.32	-27
Change in Accounts Receivable	-97	-77	-134	-107	19	-129	54	-18	-32	-64	-27	-28	-35	-37	-20	-31	-25	-33
Change in Inventory	-9.92	-80	172	-249	-312	-22	-70	-84	1.49	-42	30	-100	-16	27	19	11	-32	-16
Change in Accounts Payable	173	91	122	31	-248	211	-23	-27	201	35	46	86	-3.15	38	73	-8.34	-6.46	51
Operating Cash Flow	1,806	1,752	1,401	693	351	737	802	459	505	414	548	383	391	403	383	283	188	239
Capital Expenditures	-156	-90	-99	-120	-135	-103	-95	-69	-63	-62	-59	-63	-73	-64	-47	-67	-57	-110
Acquisitions	-351	-139	-133	-1,013	-43	-39	-28	-951	-0.90	-7.27	-1,042	-29	-3.85	-5.42	-53	-22	-11	-2.39
Sale of Property, Plant & Equipment	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	0	0.45	1.76
Purchase of Investments	-29	-6.42	-13	-32	-21	-22	-32	-47	-14	-6.46	-8.97	-11	-11	-2.23	-4.80	-2.43	0	-2.27
Sale & Maturity of Investments	2.75	4.63	1.00	3.94	6.80	0	0	–	–	–	–	–	–	–	0	3.95	1.05	0
Investing Cash Flow	-545	-200	-270	-1,160	-230	-158	-180	-1,076	-102	-82	-1,126	-143	-95	-78	-102	-77	-58	-109
Dividends Paid	-350	-311	-282	-258	-245	-227	-225	-212	-199	-186	-168	-157	-142	-97	–	–	–	–
Share Repurchases	-700	-300	-150	0	0	–	–	-23	-54	–	-102	-160	-202	-186	-393	-163	-131	-69
Stock Issued	75	74	53	49	47	38	48	37	39	38	28	39	33	69	62	95	95	25
Debt Issued	0	0	105	1,070	288	90	1,190	1,519	350	450	1,140	180	558	150	270	98	0	80
Debt Repaid	-10	-40	-835	-405	-166	-612	-1,284	-712	-1,146	-545	-284	-182	-560	-100	-126	-124	-38	-38
Taxes Paid on Share-Based Awards	-22	-18	-8.76	-31	-52	-50	-46	–	–	–	–	–	–	–	–	–	–	–
Financing Cash Flow	-1,007	-606	-1,119	423	-128	-765	-317	581	-1,027	-263	613	-256	-297	-154	-177	-79	-61	1.87
Foreign Exchange Rate Adjustments	6.18	26	-1.72	-2.15	-14	18	11	-5.56	-9.74	21	-21	-173	31	-104	-30	119	4.35	-37
Net Change in Cash	260	971	10	-46	-22	-168	316	-42	-633	91	14	-188	30	67	74	246	73	95
Free Cash Flow	1,650	1,662	1,302	574	216	634	707	390	442	352	489	321	319	339	336	217	131	129
Income Taxes Paid	357	214	278	217	478	221	180	243	171	93	69	49	90	86	55	85	97	17
Interest Paid	27	28	46	47	22	24	40	36	28	28	11	5.78	6.13	6.39	4.79	1.76	2.67	5.97

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 61.1%
Operating margin: 33.4%
Net margin: 26.9%
Return on equity, FY2026: 24.3%

Financial strength

Current ratio: 3.10
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 105.3%

Valuation

P/E ratio: 22.0
Price to sales: 5.87
Price to book: 5.04
Dividend yield: 1.04%